TDSGF (Telo Genomics) 3-Year Share Buyback Ratio: -19.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Telo Genomics 3-Year Share Buyback Ratio?

Telo Genomics TDSGF 3-Year Share Buyback Ratio is -19.00 as of Mar. 2026. The stock has 2 warning signs investors should review. Among 172 Medical Diagnostics & Research companies, Telo Genomics ranks worse than 79.65% on this metric.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Telo Genomics's current 3-Year Share Buyback Ratio was -19.00%.

The historical rank and industry rank for Telo Genomics's 3-Year Share Buyback Ratio or its related term are showing as below:

TDSGF' s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -151.6   Med: -56.9   Max: 1.6
Current: -19

During the past 13 years, Telo Genomics's highest 3-Year Share Buyback Ratio was 1.60%. The lowest was -151.60%. And the median was -56.90%.

TDSGF's 3-Year Share Buyback Ratio is ranked worse than
79.65% of 172 companies
in the Medical Diagnostics & Research industry
Industry Median: -2.6 vs TDSGF: -19.00

Telo Genomics (OTCPK:TDSGF) 3-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Telo Genomics 3-Year Share Buyback Ratio Related Terms

TDSGF vs TMO, DHR, IDXX: 3-Year Share Buyback Ratio Comparison

For the Diagnostics & Research subindustry, Telo Genomics's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Telo Genomics 3-Year Share Buyback Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Telo Genomics's 3-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Telo Genomics's 3-Year Share Buyback Ratio falls into.


Telo Genomics 3-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

What does a 3-Year Share Buyback Ratio of -19.00 mean?
Telo Genomics (TDSGF) has a 3-Year Share Buyback Ratio of -19.00 as of Mar. 2026. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Telo Genomics and its competitors. According to the industry distribution chart, Telo Genomics ranks #137 out of 172 companies in the Medical Diagnostics & Research industry, placing it in the top 79.7%.
Is Telo Genomics' 3-Year Share Buyback Ratio too high?
Telo Genomics' current 3-Year Share Buyback Ratio is -19.00. Based on the distribution chart, Telo Genomics ranks #137 out of 172 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Telo Genomics' 3-Year Share Buyback Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Telo Genomics ranks #137 out of 172 companies for 3-Year Share Buyback Ratio. This places Telo Genomics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Share Buyback Ratio for a Medical Diagnostics & Research company?
A good 3-Year Share Buyback Ratio depends on the Medical Diagnostics & Research industry context. However, 3-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Share Buyback Ratio mean?
A high 3-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Telo Genomics and its competitors. Telo Genomics's current 3-Year Share Buyback Ratio is -19.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Telo Genomics stock overvalued right now?
Telo Genomics (TDSGF) has a current 3-Year Share Buyback Ratio of -19.00. The current 3-Year Share Buyback Ratio is -19.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Share Buyback Ratio calculated?
3-Year Share Buyback Ratio is calculated from a company's financial statements. For Telo Genomics (TDSGF), the current 3-Year Share Buyback Ratio is -19.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Telo Genomics Business Description

Other Exchanges 3D0A:GermanyTELO:Canada
Address 2255 York Avenue, Suite 203, Vancouver, BC, CAN, V6K 1C5
Telo Genomics Corp is a personalized medicine company. The company through its wholly-owned subsidiary is engaged in developing diagnostic and prognostic products that may save lives, improve the quality of life, and reduce the cost of care associated with numerous diseases that display genomic instability. The company has a single operating segment, focused on the development and commercialization of predictive technological products designed to personalize treatment plans for patients who have specific conditions.